首页> 美国卫生研究院文献>Gland Surgery >Factors leading to pancreatic resection in patients with pancreatic cancer: a national perspective

【2h】

Factors leading to pancreatic resection in patients with pancreatic cancer: a national perspective

机译：导致胰腺癌患者胰腺切除的因素：国家观点

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundResection is the only option for potential cure in pancreatic cancer. Patients admitted for resection may have the procedure deferred during their hospitalization. We aim to identify factors that lead pancreatic cancer patients to undergo resection.

机译：BackgroundResection是胰腺癌潜在治愈的唯一选择。接受切除的患者可在住院期间推迟手术。我们旨在确定导致胰腺癌患者进行切除的因素。

著录项

期刊名称 Gland Surgery
作者
David T. Pointer Jr; Zaid Al-Qurayshi; John B. Hamner; Douglas P. Slakey; Emad Kandil;
展开▼
作者单位

展开▼
年(卷),期 2018(7),2
年度 2018
页码 207–215
总页数 9
原文格式 PDF
正文语种
中图分类
关键词
入库时间 2022-08-17 12:09:04

相似文献

外文文献
中文文献
专利

1. Response to the Comment on "'Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer': What Is Good for the Surgeon Is Just as Good for the Patient?'' The Case of Unresectable Pancreatic Cancer After Neoadjuvant Treatment [J] . Annals of Surgery . 2020,第4期

机译：回应关于新辅助治疗后生存率的预后因素对初始不可切除的胰腺癌的预后因素'：对外科医生的好处对患者同样好吗？“新辅助治疗后不可切除的胰腺癌的情况
2. Systematic review and meta-analysis of postoperative pancreatic fistula rates using the updated 2016 International Study Group Pancreatic Fistula definition in patients undergoing pancreatic resection with soft and hard pancreatic texture [J] . Dilmurodjon Eshmuminov, Marcel A. Schneider, Christoph Tschuor, HPB: the official journal of the International Hepato Pancreato Biliary Association . 2018,第11期

机译：系统评价和术后胰瘘率的术术胰岛素率利用更新的2016年国际研究组胰腺瘘定义，伴有软硬胰腺纹理的胰腺切除术患者
3. Familial Pancreatic Cancer Patients Have Higher Surgical Resection and Survival Compared Sporadic Pancreatic Cancer Patient [J] . Garg S. K., Ravella B., Singh D., Pancreas . 2019,第10期

机译：家族胰腺癌患者具有更高的外科切除和生存比较散发性胰腺癌患者
4. Incremental Successes in Pancreatic and Hepatobiliary Cancers Lead to Improved Patient Care [C] . Margaret A. Tempero Gastrointestinal Cancers Symposium . 2013

机译：胰腺和肝胆癌中的增量成功导致患者护理改善
5. APE1/Ref-1 Redox Signaling Regulates HIF1a-Mediated CA9 Expression in Hypoxic Pancreatic Cancer Cells: Combination Treatment in Patient-Derived Pancreatic Tumor Models [D] . Logsdon, Derek Paul. 2018

机译：APE1 / Ref-1氧化还原信号调节低氧胰腺癌细胞中HIF1a介导的CA9表达：患者源性胰腺肿瘤模型的联合治疗
6. Menstrual and Reproductive Factors Hormone Use and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (Panc4) [O] . Leila Lujan-Barroso, Wei Zhang, Sara H. Olson, -1

机译：月经和生殖因素激素使用和胰腺癌的风险：国际胰腺癌病例对照协会（Panc4）的分析
7. Table 5.5.a.1 Tumor size and treatment (rate of resectability) Figure 5.5.a.2 Cumulative survival of the patients after pancreatectomy for TS1 cancer according to residual tumors Figure 5.5.a.3 Cumulative survival of the patients with TS1 cancer according to extent of lymph node dissection Figure 5.5.a.4 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.5 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.6 Combined resection of peripancreatic plexus when there is no plexus infiltration and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.7 Combined resection of artery and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.8 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.9 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head [O] . 2007

机译：表5.5.a.1肿瘤大小和治疗（重新切性率）图5.5.a.2根据残留肿瘤对TS1癌胰腺切除后患者的累积存活图5.5.A.3累积存活根据淋巴结解剖的程度，TS1癌症的患者图5.5.A.4在胰头胰腺IIA或IIB癌症术后胰岛切除术后的门静脉和累积患者的累积存活图5.5。 A.5在胰头术后IIA或IIB胰腺切除术后，患者胰腺癌丛和患者累积存活的组合图5.5.A.6当没有丛浸润时，围裙丛生的围嘴巴丛的切除胰腺切除术后胰腺切除术后胰腺炎癌症的累积存活图5.5.A.7在TS1癌症胰腺切除后患者的动脉和累积存活的组合UICC阶段IIA或IIB在胰头图5.5.A.8在胰头胰腺阶段IIA或IIB癌症的胰腺切除后，患者的门静脉和累积患者的累积存活率图5.5.A.9在胰头胰腺阶段IIA或IIB的胰腺切除术后胰腺切除术后患者患者患者患者的累积生存的组合和胰腺头

Factors leading to pancreatic resection in patients with pancreatic cancer: a national perspective

摘要

著录项

相似文献

相关主题

期刊订阅